BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17171490)

  • 21. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's esophagus and medications that relax the lower esophageal sphincter.
    Corley DA; Levin TR; Habel LA; Buffler PA
    Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Barrett's oesophagus: place of antireflux surgery].
    Mabrut JY; Baulieux J
    Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
    Lagergren J; Mattsson F; Nyrén O
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus.
    Parrilla P; Martínez de Haro LF; Ortiz A; Munitiz V; Molina J; Bermejo J; Canteras M
    Ann Surg; 2003 Mar; 237(3):291-8. PubMed ID: 12616111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic antireflux surgery in the treatment of gastroesophageal reflux in patients with Barrett esophagus.
    Yau P; Watson DI; Devitt PG; Game PA; Jamieson GG
    Arch Surg; 2000 Jul; 135(7):801-5. PubMed ID: 10896373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Management of Barrett's Esophagus.
    Peyre CG; Watson TJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):459-71. PubMed ID: 26021205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of Barrett's mucosa to adenocarcinoma after antireflux surgery: radiologic-pathologic correlation.
    Agha FP
    Dysphagia; 1987; 2(2):117-22. PubMed ID: 3507296
    [No Abstract]   [Full Text] [Related]  

  • 32. [Symptoms in patients with adenocarcinoma of the esophagus].
    Leers J; Bollschweiler E; Hölscher AH
    Z Gastroenterol; 2005 Mar; 43(3):275-80. PubMed ID: 15765300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
    Lagergren J
    Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?
    Lagergren J
    Best Pract Res Clin Gastroenterol; 2006; 20(5):803-12. PubMed ID: 16997162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and significance of Barrett's esophagus.
    DeVault KR
    Dig Dis; 2000-2001; 18(4):195-202. PubMed ID: 11356990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.
    Smith KJ; O'Brien SM; Smithers BM; Gotley DC; Webb PM; Green AC; Whiteman DC
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2481-6. PubMed ID: 16284367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between gastroesophageal reflux, intestinal metaplasia and adenocarcinoma of the esophagus.
    Stein HJ; Feith M; Feussner H
    Langenbecks Arch Surg; 2000 Aug; 385(5):309-16. PubMed ID: 11026701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.
    Sawada A; Fujiwara Y; Nagami Y; Tanaka F; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Gi M; Wanibuchi H; Arakawa T
    Dig Dis Sci; 2016 Nov; 61(11):3161-3168. PubMed ID: 27461059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.